← Back to Patent Explorer
US4358455A Expired / Lapsed US ⏱️ 0.0 years remaining

Aralkylamindethanol heterocyclic compounds

Assignee: Merck Sharp & Dohme (I.A.) Corp
•
Filing: 1980-12-23
•
Granted: 1982-11-09
•
Expires: 2000-12-23
📄 Original PDF 🌐 Google Patents 🔄 Sync Now

Abstract

Abstract Heterocyclic aminoethanols of the formula Het-CHOH-CH2-NH-aralkyl where het is a 6-10 membered N heterocycle are disclosed. The compounds are useful as pharmaceuticals.

Inventors

  • 👤 Joseph G. Atkinson
  • 👤 John J. Baldwin
  • 👤 David E. McClure

Bibliographic Details

Application Number —
Jurisdiction US
Data Source google_patents
Last Synchronized 2026-10-28 14:53
CPC Classifications
C; C07; C07D; C07D213/00; C07D213/02; C07D213/04; C07D213/60; C07D213/62; C07D213/63; C07D213/64; C07D213/61; C07D213/72; C07D213/73; C07D213/89; C07D263/00; C07D263/52; C07D263/54; C07D263/58; C07D265/00; C07D265/28; C07D265/34; C07D265/36; C07D405/00; C07D405/02; C07D405/04; C07D471/00; C07D471/02; C07D471/04

Claims Analysis

Total Claims: 28
Claim 1
Independent Claim 83 words
Compounds of the formula: ##STR48## tautomers, pharmaceutically acceptable salts and individual enantiomers thereof wherein R 1 is H or OH, ##STR49## wherein R 4 and R 5 are independently selected from H and C 1 -C 3 alkyl, Y is CH 2 , (CH 2 ) 2 , (CH 2 ) 3 , (CH 2 ) 4 or --CH 2 --O-- R 6 is H, OH, OCH 3 , halogen, methylenedioxy or C 1 -C 3 alkyl and n is 1 or 2.
Claim 2
Dependent Claim 83 words
Compounds of the formula: ##STR48## tautomers, pharmaceutically acceptable salts and individual enantiomers thereof wherein R 1 is H or OH, ##STR49## wherein R 4 and R 5 are independently selected from H and C 1 -C 3 alkyl, Y is CH 2 , (CH 2 ) 2 , (CH 2 ) 3 , (CH 2 ) 4 or --CH 2 --O-- R 6 is H, OH, OCH 3 , halogen, methylenedioxy or C 1 -C 3 alkyl and n is 1 or 2.
Claim 3
Dependent Claim 18 words
The compounds of claim 1 formula (a) where R 1 is H, (e) and (g) and its tautomers.
Claim 4
Dependent Claim 15 words
The compounds of claim 2 wherein R 6 is H, OH or OCH 3 .
Claim 5
Dependent Claim 11 words
The compounds of claim 3 wherein Y is CH 2 O.
Claim 6
Dependent Claim 16 words
The compounds of claim 3 wherein Y is CH 2 or (CH 2 ) 2 .
Claim 7
Dependent Claim 13 words
The compounds of claim 5 wherein Y is (CH 2 ) 2 .
Claim 8
Dependent Claim 24 words
The compounds of claim 6 wherein R 3 is ##STR50## wherein R 4 , and R 5 , are either CH 3 or H.
Claim 9
Dependent Claim 10 words
The compounds of claim 7 wherein R 4 is H.
Claim 10
Dependent Claim 10 words
The compounds of claim 7 wherein R 3 is ##STR51##
Claim 11
Dependent Claim 10 words
Compounds of claim 2 having formula (a), (e) or (g).
Claim 12
Dependent Claim 8 words
The compounds of claim 10 having formula (g).
Claim 13
Dependent Claim 12 words
The compounds of claim 10 having the formula ##STR52## and tautomers thereof.
Claim 14
Dependent Claim 12 words
The compound of claim 12 having the formula ##STR53## and its tautomers.
Claim 15
Dependent Claim 18 words
A compound of claim 1 having the formula: ##STR54## their maleate or HCl salts, individual enantiomers and tautomers.
Claim 16
Dependent Claim 8 words
Compounds (c), (d) and (e) of claim 14.
Claim 17
Dependent Claim 5 words
Compound (c) of claim 14.
Claim 18
Dependent Claim 5 words
Compound (d) of claim 14.
Claim 19
Dependent Claim 5 words
Compound (e) of claim 14.
Claim 20
Dependent Claim 28 words
Pharmaceutical compositions for (a) reducing intraocular pressure (b) treating hypertension or (c) effecting bronchodilation containing a therapeutically effective amount of a compound of claim 1 and a carrier.
Claim 21
Dependent Claim 31 words
A method for (a) reducing intraocular eye pressure (b) treating hypertension by or (c) effecting bronchodilation by administering an effective amount of a claim 1 compound in a suitable dosage form.
Claim 22
Dependent Claim 9 words
The S,S isomer of the claim 13 compound claim.
Claim 23
Dependent Claim 8 words
The S,R isomer of the claim 13 compound.
Claim 24
Dependent Claim 8 words
The R,S isomer of the claim 13 compound.
Claim 25
Dependent Claim 8 words
The R,R isomer of the claim 13 compound.
Claim 26
Dependent Claim 11 words
Compounds of claim 1 formula (a) where R 1 is OH.
Claim 27
Dependent Claim 24 words
Compounds of the formula Het-CHOH-CH.sub.2 -NH.sub.2 wherein Het has the formula ##STR55## tautomers and individual isomers thereof, where R 1 is H or OH.
Claim 28
Dependent Claim 24 words
Compounds of the formula Het-CHOH-CH.sub.2 -NH.sub.2 wherein Het has the formula ##STR55## tautomers and individual isomers thereof, where R 1 is H or OH.

References Cited (Backward Citations)

US3644353A Cited
US3705233A Cited
US3952101A Cited

USPTO Annuity & Maintenance Windows

Annuity Stage Window Opens Payment Deadline Surcharge Period Until Estimated Fee Status
3.5 Years (Year 4) 1985-11-08 1986-05-10 1986-11-09 $2000.00 Window Closed / Lapsed
7.5 Years (Year 8) 1989-11-08 1990-05-10 1990-11-09 $3760.00 Window Closed / Lapsed
11.5 Years (Year 12) 1993-11-08 1994-05-10 1994-11-09 $7700.00 Window Closed / Lapsed

Assigned Categories & Tags

No categories assigned to this patent yet.

Assign Category Tag